Tadalafil 62332-0180
Product NDC
62332-0180- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 26, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA204809
Need to source Tadalafil? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tadalafil | 20 mg/1 |
Drug Class
Phosphodiesterase 5 Inhibitor [EPC]Phosphodiesterase 5 Inhibitor [EPC]Phosphodiesterase 5 Inhibitors [MoA]
Packaging Options(3)
30 TABLET, COATED in 1 BOTTLE (62332-180-30)
500 TABLET, COATED in 1 BOTTLE (62332-180-71)
1000 TABLET, COATED in 1 BOTTLE (62332-180-91)